hrp0095p1-417 | Adrenals and HPA Axis | ESPE2022

A patient with autoimmune polyglandular syndrome type 1 with atypical presentation

Bazdarska Yuliya , Yordanova Nikolinka , Hristozova Hristina , Krumova Darina , Iotova Violeta

Background: Autoimmune polyglandular syndrome type 1 (APS-1) is а rare multisystem disorder due to mutations in the autoimmune regulator gene (AIRE). APS-1 usually is characterized by a triad of hypoparathyroidism, primary adrenal insufficiency (PAI) and chronic mucocutaneous candidiasis. In the absence of the classic triad, the diagnosis becomes obscure and is often delayed.Case presentation: We report a 12 years ol...

hrp0097p2-231 | Growth and Syndromes | ESPE2023

Growth hormone treatment of short SGA children – experience of tertiary clinic in Bulgaria

Krumova Darina , Zlateva Tanya , Georgieva Ralitsa , Deyanova Yana , Iotova Violeta

Introduction: Fenton (2013) defined small for gestational age children (SGA) as born with birth length and/or weight < 10th percentile for the corresponding gestational age, and clinicians use it ever since. According to the literature, 1 of 10 children born SGA does not catch-up in growth. Wit (2021) suggested to address them as short SGA children. Recombinant human growth hormone (rhGH) treatment in those children have been approved by the FDA in 2001 and...

hrp0095p2-131 | Fetal, Neonatal Endocrinology and Metabolism | ESPE2022

Small for Gestational Age (SGA) Babies Identified Through in the Pilot Programme for Early Detection and Follow-Up of SGA Children

Zlateva Tanya , Tsochev Kaloyan , Krumova Darina , Pramatarova-Kamburova Tanya , Krasteva-Vilmosh Maya , Georgieva Ralitsa , Iotova Violeta

Introduction: Children born small for gestational age (SGA) are extensively studied since the 60s of the last century. Short-term and long term sequels of the condition lead to the concept of necessary follow up throughout childhood and early adulthood. Based on the current knowledge, SGA births are between 5% and 7% of all, with about 10% failing to catch-up up to 2 years of age. The timely capture of such individuals within general practices and even within ...

hrp0097p1-475 | Fat, Metabolism and Obesity | ESPE2023

A girl with ROHHAD syndrome – a rare cause of rapid-onset obesity and hypothalamic dysfunction

Galcheva Sonya , Hachmeriyan Mari , Krumova Darina , Georgiev Radoslav , Dancheva Zhivka , Begemann Matthias , Eggermann Thomas , Iotova Violeta

Background: The rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation (ROHHAD) is a long-known rare condition with a high morbidity and mortality rate, and still unknown etiology.Objective: We aim to present the clinical findings and treatment in a patient with ROHHAD syndrome.Case presentation: A 4-year-old girl had normal development until March 2022 whe...

hrp0095p1-409 | Adrenals and HPA Axis | ESPE2022

Clinical, laboratory and body composition profile of young female patients with non-classic congenital adrenal hyperplasia

Karamfilova Teodora , Galcheva Sonya , Bocheva Yana , Ivanova Darina , Bazdarska Yuliya , Iotova Violeta

Background: Non-classic congenital adrenal hyperplasia (NCCAH) is a genetic disorder characterized by hyperandrogenism associated with potential metabolic alterations and changes in body composition and bone mineral parameters.Aim: The purpose of this pilot study was to evaluate the clinical and biochemical characteristics in association with bone mineral parameters and body composition in female patients diagnosed with ...

hrp0097p1-579 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2023

Comparison between clinical, metabolic and hormonal parameters in adolescent girls with hyperandrogenism and healthy controls

Mladenov Vilhelm , Galcheva Sonya , Karamfilova Teodora , Bocheva Yana , Ivanova Darina , Iotova Violeta

Background: Polycystic ovary syndrome (PCOS) and non-classical congenital adrenal hyperplasia (NCCAH) are the most common hyperandrogenic disorders in adolescent girls. Though their etiology and pathogenesis differ, there is a significant overlap between physiological, clinical and hormonal findings and physiological phenomena. Adult patients with PCOS have increased prevalence of obesity, metabolic disturbances, increased cardiovascular risk, risk of impaired...

hrp0092p1-328 | Diabetes and Insulin (2) | ESPE2019

Creating a Neural Network Model Based on Glycemic Variability Indices to Predict the Degree of Compensation for Type 1 Diabetes

Koshmeleva Marina , Samoilova Juliya , Kobyakova Olga , Oleynik Oxana , Brazovskii Konstantin , Nazarenko Valeriya , Filippova Tatiyana , Podchinenova Dariya

Actuality: Standard methods for determining the compensation of the disease don't always reliably reflect the level of the glycemic control of the patient, which leads to decompensation diabetes and reduce the quality and duration of life for patients. Evaluation of glycemic variability indices allows the physicians to predict the risk of developing life-threatening conditions and compensate the diabetesAim: To condu...

hrp0082p3-d3-844 | Growth (2) | ESPE2014

WHO Growth Charts Replacing National Reference Data: Their Influence on Screening for Over- or Underweight and of Growth Disorders

Eisenegger Celine , Allenspach-Moser Sarina , Lallemand Dagmar

Background: In 2011, nationwide growth charts were introduced, replacing different regional references (ZLS, Prader 1989; Sempé 1979 and, for BMI only, Kromeyer 2001).Objective and hypotheses: The aim was to examine the influence of new growth charts (WHO 2010) on the prevalence of nutrition- and growth-related disorders compared the ‘old’ references.Method: 6007 anonymised weight and height datasets of children meas...

hrp0082p1-d1-198 | Reproduction | ESPE2014

Stability Conditions in Estradiol Matrix Patches; in vitro Studies for Application in Pediatrics

Ankarberg-Lindgren Carina , Sas Theo

Background: We have previously shown that estradiol (E2) matrix patches for adults could be cut in smaller pieces to administer low doses for pubertal induction in girls with hypogonadism. With a slow increase of the patch size during a few years, serum E2 levels in normal girls undergoing puberty can be closely mimicked.Objective and hypotheses: To evaluate storage conditions once the patch has been cut.Metho...

hrp0084wg6.5 | Turner Syndrome | ESPE2015

Report on the Progress and Difficulties on Transdermal Estradiol Supplementation in Europe

Sas Theo , Ankarberg-Lindgren Carina

Background: The Turner syndrome (TS) Working Group of the ESPE intends to start an international study comparing transdermal estradiol (E2) vs oral E2 in Europe in girls with TS. For this, stable and reliable products for children are needed, for use in different countries with different climates. It has previously been shown that E2 matrix patches for adults can be cut in smaller pieces to administer low doses for pubertal induction in girls. The Turner Working Group plan to ...